Continuus Pharmaceuticals is a pioneering CDMO based in Woburn, Massachusetts, specializing in Integrated Continuous Manufacturing (ICM) technology for small-molecule pharmaceuticals. The company replaces traditional batch processes with end-to-end continuous manufacturing, transforming raw materials into APIs and finished dosage forms in days rather than months. Continuus has received FDA and BARDA partnerships and a $69.3M DoD grant, and is building a $125 million manufacturing facility in Woburn.
Integrated Continuous Manufacturing (ICM), flow chemistry, continuous crystallization, continuous drying, continuous formulation, end-to-end API to drug product
1 site worldwide
Involvement in 4 clinical trials
No reviews available yet.
No documents available.